Comment on "Bibliometric analysis reveals the research hotspots and trends of nasopharyngeal carcinoma immunotherapy".
Heng Bai, Si-Yang Liu, Jie Tian, Yu Li
Author Information
- Heng Bai: Department of General Practice/Department of Geriatrics, The Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China.
- Si-Yang Liu: Department of General Practice/Department of Geriatrics, The Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China.
- Jie Tian: Department of Thoracic Surgery/Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
- Yu Li: Department of General Practice/Department of Geriatrics, The Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China.
No abstract text available.
- Cell Death Discov. 2023 Jul 10;9(1):238
[PMID: 37429861]
- Gigascience. 2022 Aug 13;11:
[PMID: 35962776]
- J Clin Oncol. 2018 May 10;36(14):1412-1418
[PMID: 29584545]
- Int J Surg. 2023 Sep 01;109(9):2829-2830
[PMID: 37352515]
- Hum Vaccin Immunother. 2024 Dec 31;20(1):2360341
[PMID: 39034441]
Humans
Nasopharyngeal Carcinoma
Immunotherapy
Nasopharyngeal Neoplasms
